Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Yunqi Capital Investment Management Firm And 5.1% Shareholder Of STAAR Surgical Announced Its Opposition To The Company's Proposed Sale To Alcon On The Terms Announced On August 5, 2025

Author: Benzinga Newsdesk | September 22, 2025 05:07am

Issues Open Letter to Shareholders Outlining Its Belief that the Proposed Merger Materially Undervalues STAAR
Contends that STAAR's Board Failed In Its Responsibilities by Not Running a Thorough Process and Relying on Undue Skepticism about the Company's Prospects
Shareholders Deserve Fair Value for the Company

Posted In: ALC STAA